Suppr超能文献

多酚类黄酮(杨梅素)上调蛋白酶体降解机制:消除神经退行性蛋白聚集。

Polyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregation.

机构信息

Cellular and Molecular Neurobiology Unit, Indian Institute of Technology, Jodhpur, Rajasthan, India.

Department of Biotechnology, Indian Institute of Technology, Roorkee, India.

出版信息

J Cell Physiol. 2019 Nov;234(11):20900-20914. doi: 10.1002/jcp.28695. Epub 2019 Apr 19.

Abstract

Major neurodegenerative disorders are characterized by the formation of misfolded proteins aggregates inside or outside the neuronal cells. Previous studies suggest that aberrant proteins aggregates play a critical role in protein homeostasis imbalance and failure of protein quality control (PQC) mechanism, leading to disease conditions. However, we still do not understand the precise mechanisms of PQC failure and cellular dysfunctions associated with neurodegenerative diseases caused by the accumulation of protein aggregates. Here, we show that Myricetin, a flavonoid, can eliminate various abnormal proteins from the cellular environment via modulating endogenous levels of Hsp70 chaperone and quality control (QC)-E3 ubiquitin ligase E6-AP. We have observed that Myricetin treatment suppresses the aggregation of different aberrant proteins. Myricetin also enhances the elimination of various toxic neurodegenerative diseases associated proteins from the cells, which could be reversed by the addition of putative proteasome inhibitor (MG132). Remarkably, Myricetin can also stabilize E6-AP and reduce the misfolded proteins inclusions, which further alleviates cytotoxicity. Taken together these findings suggested that new mechanistic and therapeutic insights based on small molecules mediated regulation of disturbed protein quality control mechanism, which may result in the maintenance of the state of proteostasis.

摘要

主要的神经退行性疾病的特征是神经元细胞内外的错误折叠蛋白聚集物的形成。先前的研究表明,异常蛋白聚集体在蛋白质平衡失衡和蛋白质质量控制(PQC)机制失效中起着关键作用,导致疾病状态。然而,我们仍然不了解与由蛋白质聚集物积累引起的神经退行性疾病相关的 PQC 失效和细胞功能障碍的确切机制。在这里,我们表明,杨梅素是一种类黄酮,可以通过调节内源性 Hsp70 伴侣和质量控制(QC)-E3 泛素连接酶 E6-AP 的水平,从细胞环境中消除各种异常蛋白质。我们观察到杨梅素处理可抑制不同异常蛋白的聚集。杨梅素还增强了各种有毒的神经退行性疾病相关蛋白从细胞中的消除,这可以通过添加假定的蛋白酶体抑制剂(MG132)来逆转。值得注意的是,杨梅素还可以稳定 E6-AP 并减少错误折叠的蛋白包涵体,从而进一步减轻细胞毒性。总之,这些发现表明,基于小分子介导的对紊乱的蛋白质质量控制机制的调节的新的机制和治疗见解,可能导致蛋白质稳态的维持。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验